Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Liquid Chromatograph (LC) coupled with Inductively Coupled Plasma Mass Spectrometer (ICP-MS)

Closed
98130Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
Federal
FY26 Lab Consolidation for Coagulation CPRR EffortThe contract solicits a comprehensive Cost Per Reportable Result (CPRR) agreement to supply and support coagulation analyzers for multiple Military Treatment Facilities (MTFs) under the Defense Health Agency HCD West. Spanning one base year with four option years, the contract encompasses all aspects necessary for effective coagulation testing, including the provision of coagulation analyzer equipment, reagents, consumables, controls, peripherals such as printers and uninterrupted power supplies, and all parts needed to ensure proper instrument operation. The CPRR price covers every element required to generate a single patient reportable result, including dilution, repeat and confirmatory testing, as well as quality control and calibration per Clinical Laboratory Standards Institute guidelines. The contractor is responsible for delivery, installation, removal, preventive maintenance, repairs, and ensuring continuous, uninterrupted analyzer operation even in cases of interface failures with laboratory information systems or electronic health records. In addition to equipment and consumables, the contract requires comprehensive training for government personnel, offering user-level and advanced super-user training sessions at both the installation sites and contractor facilities, with contractor-borne travel expenses for the latter. The analyzers must be new, FDA-approved, and capable of seamless bidirectional interfacing with existing Department of Defense electronic health records and laboratory management systems. The scope also includes managing hazardous waste generated during testing and accommodating varying workload volumes, surge capacity, and volume adjustments at different MTFs. Detailed site-specific data informs equipment deployment, covering delivery schedules, physical requirements, power needs, and anticipated test volumes for various coagulation assays such as Prothrombin Time and Activated Partial Thromboplastin Time. The contractor is tasked with providing ongoing operational and technical support, monthly reporting, and ensuring overall performance quality throughout the contract term.
Defense Health Agency Hcd West

POSTED

1 day ago

DEADLINE

in 9 days
NAICS: 334516
New
Federal
NOI - PCA-NHLBI-07088The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under solicitation number 75N98026Q00630 to procure two complete CD Leycom INCA Pressure-Volume Loop Systems along with associated accessories, disposable catheters, and platinum-level training and support. This procurement supports clinical studies conducted by the National Heart, Lung, and Blood Institute’s Laboratory of Cardiovascular Intervention under an Investigational Device Exemption. The purchase will be awarded as a firm-fixed-price order to CD Leycom BV, the sole worldwide manufacturer of this invasive conductance-catheter-based system, which holds FDA 510(k) market clearance for clinical use in human patients. Due to the unique capabilities of CD Leycom’s system and its regulatory approval status, no other vendor can provide an equivalent product, justifying the non-competitive acquisition approach. This acquisition is conducted under FAR Part 12.603 for streamlined solicitation of commercial products and services and falls below the simplified acquisition threshold. It is issued as a Notice of Intent without plans for full and open competition, referencing authorities including FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; however, this requirement is not set aside for small businesses. The solicitation incorporates provisions effective as of March 13, 2026, per the latest Federal Acquisition Circular. The response deadline is set for June 23, 2026, with point of contact information provided for coordination.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC) plans to award a sole source, firm fixed price contract to Agilent Technologies, Inc. for the purchase of an integrated Liquid Chromatograph (LC) coupled with an Inductively Coupled Plasma Mass Spectrometer (ICP-MS) system. This decision is driven by the unique compatibility of the Agilent 1260 Infinity III LC linked with the Agilent 7900 ICP-MS and its seamless integration with the existing Agilent MassHunter software platform currently used within the CDC's Respiratory Health Division laboratories. This integration facilitates continuity in validated analytical methods, minimizes training needs, reduces operational downtime, and ensures consistent data processing, which no other vendor can provide. Extensive market research identified only one other vendor with a comparable product, but that alternative system lacks essential integration with the CDC’s existing software and would require retraining, workflow modifications, and incur additional costs approximately $100,000 higher without equivalent benefits. Such changes would risk delays, increased costs, and disruption of ongoing research, making Agilent Technologies the only viable source meeting all governmental requirements. The contract process is being conducted under the authority of FAR 6.103-1, with the CDC inviting any possible quotations within 15 days of the notice issuance; however, the government reserves sole discretion on whether to compete. The contract will be executed in Atlanta, Georgia, under the CDC Office of Acquisition Services.

General Info

CDC awards sole source contract to Agilent for integrated LC-ICP-MS system with existing software compatibility.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts1 person available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
Office AddressATLANTA, GA, 30333, USA
Contacts
Iris Gonzalez

Full Description

Show more

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Agilent Technologies, Inc. for the Liquid Chromatograph (LC) coupled to Inductively Coupled Plasma (ICP) Mass Spectrometer (MS ).


The Agilent 1260 Infinity III liquid chromatograph (LC) coupled with the Agilent 7900 inductively coupled plasma–mass spectrometer (ICP-MS) provides a fully integrated LC-ICP-MS system that is compatible with the existing laboratory instrumentation and software platform (Agilent MassHunter) currently in use within the Respiratory Health Division/Field Studies Branch laboratories. This compatibility enables seamless integration with established analytical workflows, including instrument control, data acquisition, and data analysis, without requiring modification of existing methods or retraining of laboratory personnel. The Agilent system uniquely allows: (1) Direct integration with existing MassHunter software used across current laboratory instrumentation (2) Continuity of validated analytical methods and workflows  Minimization of training requirements and operational downtime (3) Consistent data processing and reporting across platforms (4) No other identified vendor provides an LC-ICP-MS system that integrates with the existing MassHunter software environment. As a result, only the Agilent system can meet the requirement for full system integration, continuity of operations, and efficient implementation within the existing laboratory infrastructure. Market research identified one vendor, as the only other vendor capable of providing an LC-ICP-MS system with similar analytical capabilities. However, the identified vendors system does not meet the Government’s requirements for compatibility with existing laboratory instrumentation and software. Specifically: (1) The system does not integrate with the Agilent MassHunter software platform currently used for instrument control and data analysis  (2)Implementation would require retraining of laboratory personnel on a new software system (3) Existing analytical methods and workflows would require modification, revalidation, or redevelopment (4) These changes would introduce delays in operational readiness and increase the risk of disruption to ongoing research activities (5) In addition to technical and operational limitations, the system was approximately $100,000 higher in cost than the Agilent system, without providing equivalent compatibility or operational efficiency. Selection of a non-compatible system would result in increased costs, extended implementation timelines, and potential impacts to data consistency and research continuity. Based on these factors, this vendor is not considered a reasonable alternative, and Agilent Technologies, Inc. is the only source capable of meeting all Government requirements.


This contract action is for supplies/service for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP).


This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by June 13, 2026 before 10am EST.